BR112021020501A2 - Meio de cultura celular para células eucarióticas - Google Patents
Meio de cultura celular para células eucarióticasInfo
- Publication number
- BR112021020501A2 BR112021020501A2 BR112021020501A BR112021020501A BR112021020501A2 BR 112021020501 A2 BR112021020501 A2 BR 112021020501A2 BR 112021020501 A BR112021020501 A BR 112021020501A BR 112021020501 A BR112021020501 A BR 112021020501A BR 112021020501 A2 BR112021020501 A2 BR 112021020501A2
- Authority
- BR
- Brazil
- Prior art keywords
- cell culture
- culture medium
- eukaryotic cells
- cells
- media
- Prior art date
Links
- 239000006143 cell culture medium Substances 0.000 title abstract 3
- 210000003527 eukaryotic cell Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/92—Medium free of human- or animal-derived components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837263P | 2019-04-23 | 2019-04-23 | |
| PCT/US2020/029370 WO2020219582A1 (en) | 2019-04-23 | 2020-04-22 | Cell culture medium for eukaryotic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021020501A2 true BR112021020501A2 (pt) | 2021-12-07 |
Family
ID=70681881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021020501A BR112021020501A2 (pt) | 2019-04-23 | 2020-04-22 | Meio de cultura celular para células eucarióticas |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10961500B1 (https=) |
| EP (1) | EP3959234A1 (https=) |
| JP (2) | JP2022529485A (https=) |
| KR (1) | KR20220003563A (https=) |
| CN (1) | CN113710696A (https=) |
| AU (1) | AU2020262117B2 (https=) |
| BR (1) | BR112021020501A2 (https=) |
| CA (1) | CA3136827A1 (https=) |
| EA (1) | EA202192893A1 (https=) |
| IL (1) | IL287387A (https=) |
| MX (1) | MX2021012649A (https=) |
| MY (1) | MY198223A (https=) |
| SG (1) | SG11202111252QA (https=) |
| WO (1) | WO2020219582A1 (https=) |
| ZA (1) | ZA202107808B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
| WO2023278525A1 (en) * | 2021-06-29 | 2023-01-05 | Biomarin Pharmaceutical Inc. | Cell culture feed for recombinant adeno-associated virus production in mammalian cells |
| CN118240749B (zh) * | 2024-05-28 | 2024-08-06 | 烟台赛普生物技术有限公司 | 一种灌流培养基及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1312030C (en) * | 1987-11-18 | 1992-12-29 | Brian Maiorella | Method to increase antibody titer |
| EP1482031B1 (en) * | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US20030096414A1 (en) * | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
| SG106672A1 (en) | 2002-03-08 | 2004-10-29 | Asml Netherlands Bv | Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method |
| ATE541919T1 (de) * | 2005-02-11 | 2012-02-15 | Novo Nordisk Healthcare Ag | Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält |
| WO2008154014A2 (en) * | 2007-06-11 | 2008-12-18 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
| BRPI0919034A8 (pt) * | 2008-09-26 | 2016-02-10 | Schering Corp | Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso |
| CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
| CA2805557A1 (en) * | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant high molecular weight vwf in cell culture |
| US9677105B2 (en) * | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TW202440904A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法（二） |
| KR102659791B1 (ko) * | 2017-07-06 | 2024-04-23 | 리제너론 파마슈티칼스 인코포레이티드 | 당단백질을 만들기 위한 세포 배양 과정 |
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
-
2020
- 2020-01-27 US US16/752,874 patent/US10961500B1/en active Active
- 2020-04-22 MY MYPI2021006125A patent/MY198223A/en unknown
- 2020-04-22 KR KR1020217037669A patent/KR20220003563A/ko active Pending
- 2020-04-22 CN CN202080030558.8A patent/CN113710696A/zh active Pending
- 2020-04-22 BR BR112021020501A patent/BR112021020501A2/pt unknown
- 2020-04-22 MX MX2021012649A patent/MX2021012649A/es unknown
- 2020-04-22 WO PCT/US2020/029370 patent/WO2020219582A1/en not_active Ceased
- 2020-04-22 EP EP20725601.7A patent/EP3959234A1/en active Pending
- 2020-04-22 JP JP2021562097A patent/JP2022529485A/ja active Pending
- 2020-04-22 EA EA202192893A patent/EA202192893A1/ru unknown
- 2020-04-22 CA CA3136827A patent/CA3136827A1/en active Pending
- 2020-04-22 SG SG11202111252QA patent/SG11202111252QA/en unknown
- 2020-04-22 AU AU2020262117A patent/AU2020262117B2/en active Active
-
2021
- 2021-03-24 US US17/211,596 patent/US11286460B2/en active Active
- 2021-10-14 ZA ZA2021/07808A patent/ZA202107808B/en unknown
- 2021-10-19 IL IL287387A patent/IL287387A/en unknown
-
2022
- 2022-02-22 US US17/677,163 patent/US11555176B2/en active Active
- 2022-12-13 US US18/080,373 patent/US11821001B2/en active Active
-
2023
- 2023-11-20 US US18/514,880 patent/US20240084248A1/en active Pending
-
2024
- 2024-11-27 JP JP2024205936A patent/JP2025028979A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025028979A (ja) | 2025-03-05 |
| US11821001B2 (en) | 2023-11-21 |
| MX2021012649A (es) | 2021-11-12 |
| KR20220003563A (ko) | 2022-01-10 |
| SG11202111252QA (en) | 2021-11-29 |
| US20230114292A1 (en) | 2023-04-13 |
| MY198223A (en) | 2023-08-14 |
| ZA202107808B (en) | 2024-11-27 |
| US10961500B1 (en) | 2021-03-30 |
| EP3959234A1 (en) | 2022-03-02 |
| IL287387A (en) | 2021-12-01 |
| US20210261913A1 (en) | 2021-08-26 |
| US20210071135A1 (en) | 2021-03-11 |
| EA202192893A1 (ru) | 2022-02-03 |
| JP2022529485A (ja) | 2022-06-22 |
| US11555176B2 (en) | 2023-01-17 |
| AU2020262117A1 (en) | 2021-11-11 |
| US20220177832A1 (en) | 2022-06-09 |
| US20240084248A1 (en) | 2024-03-14 |
| US11286460B2 (en) | 2022-03-29 |
| AU2020262117B2 (en) | 2026-02-12 |
| WO2020219582A1 (en) | 2020-10-29 |
| CN113710696A (zh) | 2021-11-26 |
| CA3136827A1 (en) | 2020-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201992795A1 (ru) | Способ получения эукариотических клеток с отредактированной днк и набор, используемый в этом способе | |
| BR112015021993A8 (pt) | polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular | |
| Pomorski et al. | Model cell membranes: Discerning lipid and protein contributions in shaping the cell | |
| MX2024005009A (es) | Dominios de union anti-cd3 y anticuerpos que los comprenden, y metodos para su generacion y uso. | |
| EP4056685A4 (en) | PRIMARY BREAST EPITHELIAL CELL CULTURE MEDIUM, CULTURE METHOD AND USE THEREOF | |
| MX2020004541A (es) | Edicion de genes de celulas primarias. | |
| BR112018002214A2 (pt) | ?métodos para cultivar células e para produzir uma proteína, meios de cultura de células cho e de batelada alimentada e/ou alimentação, e, alimentação de cultura de células cho? | |
| BR112021020501A2 (pt) | Meio de cultura celular para células eucarióticas | |
| EP3947642A4 (en) | CULTURE MEDIUM FOR MAMMALIAN PLURIPOTENTE STEM CELLS, COMPOSITION AND METHODS | |
| BR112016028512A8 (pt) | método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante | |
| BR112014000042A2 (pt) | composição, meio de cultura celular, uso de uma composição, e, método para cultivar células | |
| PL439808A1 (pl) | Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał | |
| AU2018335876A1 (en) | In situ combinatorial labeling of cellular molecules | |
| BR112015009774A2 (pt) | polipeptídeos citocromo p450 e citocromo p450 redutase, codificando moléculas de ácido nucléicos e usos das mesmas | |
| BR112015022529A2 (pt) | meios de cultura de células e processos de produção de anticorpo | |
| MX2020009648A (es) | Muestreador de lecho fijo y metodos relacionados. | |
| WO2019121961A3 (en) | Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin | |
| EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
| BR112017006533A2 (pt) | usos de trealose em suspensões celulares | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| EA202091349A1 (ru) | Способы культивирования клеток | |
| CL2024001654A1 (es) | Anticuerpos antimutantes de calreticulina (calr) y usos de los mismos. | |
| BR112017000142A2 (pt) | ajuste de ph para melhorar recuperação de criopreservação de bancos de células | |
| MX2021001981A (es) | Metodos para preparar un poloxamero para usar en medio de cultivo celular. | |
| BR112021021349A2 (pt) | Métodos de fabricação de células car t alogênicas |